Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06721455 · ClinicalTrials.gov registry record

Modeling Blood Management and Hemolytic Risk in Pediatric Heart Surgery

A clinical trial of Blood Transfusion and Hemolysis, sponsored by Boston Children's Hospital.

Recruiting
Registry status
50
Enrollment target
1
Study location

NCT06721455: Recruiting study of Blood Transfusion and Hemolysis, sponsored by Boston Children's Hospital.

NCT06721455 is a study of Blood Transfusion and Hemolysis that is actively recruiting participants, run by Boston Children's Hospital. The registered enrollment target is 50 participants, below the 287-participant average among 3 other Blood Transfusion trials with a reported enrollment target (83% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06721455, a study of Blood Transfusion and Hemolysis, is actively recruiting participants, sponsored by Boston Children's Hospital.

RECRUITING
Registry status
50 participants
Enrollment target
1
Study location

Study Summary

This study aims to learn more about blood management in children undergoing heart surgery, such as the right amounts, and the best blood products, to administer. It also aims to develop a mathematical model that may help researchers better predict and treat patients who need blood transfusions during heart surgery.

Interventions

  • OTHER blood sampling

Study Locations (1)

Massachusetts

  • Boston Children's Hospital - Boston

Trial Details

FieldValue
Enrollment Target 50 participants
Start Date 2025-08-01
Est. Completion 2026-12-31
Boston Children's Hospital

462 total trials

What NCT06721455 shows while recruiting

NCT06721455 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 50 participants, a relatively small participant target, below the 287-participant average among 3 other Blood Transfusion trials with a reported enrollment target (83% lower).

The record links to 3 conditions, with Blood Transfusion appearing as the primary indexed condition, and to 1 intervention - of which blood sampling is the first listed.

NCT06721455 reports a single indexed study location in Massachusetts.

Frequently Asked Questions

What is clinical trial NCT06721455 about?

NCT06721455 is a clinical study titled "Modeling Blood Management and Hemolytic Risk in Pediatric Heart Surgery". This study aims to learn more about blood management in children undergoing heart surgery, such as the right amounts, and the best blood products, to administer. It also aims to develop a mathematical model that may help researchers better predict and treat patients who need blood transfusions durin...

What is the current status of trial NCT06721455?

This trial is currently recruiting. The enrollment target is 50 participants. The study started on 2025-08-01. Estimated completion is 2026-12-31.

What conditions does trial NCT06721455 study?

This clinical trial studies the following conditions: Blood Transfusion, Hemolysis, Heart Surgery.

What interventions are being tested in trial NCT06721455?

The interventions under investigation include: blood sampling (OTHER).

Who is sponsoring clinical trial NCT06721455?

This trial is sponsored by Boston Children's Hospital, which has 462 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06721455 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Blood Transfusion

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00200889 · 50 participants · Early Phase 1

    Mapping Auricular Vagus Nerve Circuitry

  • NCT00409435 · 50 participants · Phase 2

    A Study of Pyridostigmine in Postural Tachycardia Syndrome

  • NCT01202305 · 50 participants

    The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies

  • NCT01225913 · 50 participants · Phase 4

    Mechanism(s) of Airflow Limitation During Exacerbation of Asthma

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06721455, the US trial registry maintained by the National Library of Medicine. NCT06721455 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.